8 результати
FIELD OF THE INVENTION
This invention relates to a pet food composition and method for reducing inflammatory response in cats. More particularly, the invention relates to a feline dietary composition that includes omega-3 (n-3) fatty acids, especially the form of the omega-3 fatty acid known as
FIELD OF THE INVENTION
The present disclosure is related to a nutritional composition, in particular a nutritional composition for patients with inflammatory bowel disease. The present disclosure also relates to a method for improving musculoskeletal health in patients, in particular patients with
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a National Stage of International Application No. PCT/EP2013/065948, filed on Jul. 30, 2013, which claims priority to European Patent Application No. 12178573.7, filed on Jul. 31, 2012, the entire contents of which are being
FIELD OF THE INVENTION
The present application relates to the field of dietary supplement and to formulations for total enteral or parenteral nutrition and the prevention of fatty acid deficiency.
BACKGROUND OF THE INVENTION
Linoleic acid and alpha-linolenic acid are two fatty acids that cannot be
FIELD OF THE INVENTION
The present application relates to the field of dietary supplement and to formulations for total enteral or parenteral nutrition and the prevention of fatty acid deficiency.
BACKGROUND OF THE INVENTION
Linoleic acid and alpha-linolenic acid are two fatty acids that cannot be
FIELD OF THE INVENTION
This invention relates to pharmaceutical preparations (which expression is herein intended to include veterinary preparations) for use in combating infective organisms afflicting the animal body (which expression is herein intended to include the human body).
This invention
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of PCT International Applications PCT/ZA01/00098, PCT/ZA01/00099, and PCT/ZA01/00100, all filed Jul. 19, 2001, and all designating the U.S.
FIELD OF THE INVENTION
This invention relates to pharmaceutical preparations
The present invention relates to new polyunsaturated fatty acids having antimalarial activity and/or neutrophil stimulatory activity. In addition, certain of the new polyunsaturated fatty acids depress cytokine activity.
Over half of the world's population is at risk from malaria, with about 500